Y-mAbs Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2025 | 4.24 M | $19.11 M | 0.00% | 9.35% |
| ACORN CAPITAL ADVISORS, LLC | 08/14/2025 | 3.42 M | $15.42 M | 5.68% | 7.54% |
| BLACKROCK, INC. | 08/12/2025 | 2.75 M | $12.39 M | -5.30% | 6.06% |
| CALIGAN PARTNERS LP | 08/14/2025 | 2.34 M | $10.57 M | 0.00% | 5.17% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2025 | 2.19 M | $9.90 M | 0.00% | 4.84% |
| VANGUARD GROUP INC | 08/11/2025 | 1.94 M | $8.76 M | -0.17% | 4.29% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2025 | 1.79 M | $8.07 M | -2.25% | 3.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 848.46 K | $3.83 M | -0.12% | 1.87% |
| STATE STREET CORP | 08/14/2025 | 780.15 K | $3.52 M | -1.12% | 1.72% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2025 | 693.69 K | $3.13 M | 0.00% | 1.53% |
| D. E. SHAW & CO., INC. | 08/14/2025 | 516.86 K | $2.33 M | -5.97% | 1.14% |
| DIMENSIONAL FUND ADVISORS LP | 08/12/2025 | 412.25 K | $1.86 M | -1.51% | 0.91% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/14/2025 | 351.88 K | $1.59 M | 100.00% | 0.78% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/15/2025 | 349.98 K | $1.58 M | 0.00% | 0.77% |
| NORTHERN TRUST CORP | 08/13/2025 | 308.13 K | $1.39 M | -6.03% | 0.68% |
| MORGAN STANLEY | 08/15/2025 | 292.57 K | $1.32 M | -41.51% | 0.65% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/13/2025 | 285.30 K | $1.29 M | 117.52% | 0.63% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 278.18 K | $1.25 M | 0.21% | 0.61% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 274.16 K | $1.24 M | -2.89% | 0.61% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2025 | 252.14 K | $1.14 M | 53.01% | 0.56% |
| UBS GROUP AG | 08/14/2025 | 229.07 K | $1.03 M | 150.14% | 0.51% |
| GOLDMAN SACHS GROUP INC | 08/14/2025 | 212.75 K | $959.51 K | 5.44% | 0.47% |
| CITADEL ADVISORS LLC | 08/14/2025 | 207.64 K | $936.47 K | 34.87% | 0.46% |
| GSA CAPITAL PARTNERS LLP | 07/22/2025 | 186.06 K | $839.00 K | 801.86% | 0.41% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 164.10 K | $740.09 K | -36.07% | 0.36% |
| JPMORGAN CHASE & CO | 08/12/2025 | 164.06 K | $739.89 K | -33.70% | 0.36% |
| INFINITUM ASSET MANAGEMENT, LLC | 08/14/2025 | 155.53 K | $701.44 K | 0.00% | 0.34% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2025 | 142.64 K | $643.31 K | -39.94% | 0.31% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 139.96 K | $631.20 K | -70.01% | 0.31% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2025 | 125.30 K | $565.09 K | -19.05% | 0.28% |
| FEDERATED HERMES, INC. | 08/13/2025 | 119.43 K | $538.61 K | -22.17% | 0.26% |
| TWO SIGMA ADVISERS, LP | 08/14/2025 | 115.70 K | $521.81 K | -19.26% | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 08/11/2025 | 109.60 K | $494.31 K | 5.75% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 08/05/2025 | 99.35 K | $448.08 K | 7.44% | 0.22% |
| BNP PARIBAS ARBITRAGE, SNC | 08/14/2025 | 94.38 K | $425.67 K | -1.17% | 0.21% |
| NUVEEN, LLC | 08/12/2025 | 93.42 K | $421.32 K | -16.95% | 0.21% |
| XTX TOPCO LTD | 08/12/2025 | 86.44 K | $389.84 K | -5.48% | 0.19% |
| BARCLAYS PLC | 08/14/2025 | 72.84 K | $329.00 K | 55.79% | 0.16% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 08/14/2025 | 69.91 K | $315.29 K | -55.05% | 0.15% |
| RHUMBLINE ADVISERS | 08/12/2025 | 68.40 K | $308.47 K | 26.88% | 0.15% |
| STRS OHIO | 08/04/2025 | 62.40 K | $281.42 K | 43.78% | 0.14% |
| JUMP FINANCIAL, LLC | 08/13/2025 | 61.50 K | $277.37 K | 61.51% | 0.14% |
| JANE STREET GROUP, LLC | 08/14/2025 | 60.87 K | $274.54 K | 100.00% | 0.13% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2025 | 59.38 K | $267.80 K | 8.40% | 0.13% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2025 | 55.70 K | $251.21 K | 123.69% | 0.12% |
| STATE OF WISCONSIN INVESTMENT BOARD | 08/14/2025 | 51.34 K | $231.53 K | 100.00% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 51.09 K | $230.42 K | -15.78% | 0.11% |
| SAPIENT CAPITAL LLC | 07/09/2025 | 43.70 K | $197.09 K | 0.00% | 0.10% |
| INVESCO LTD. | 08/13/2025 | 42.83 K | $193.18 K | 31.60% | 0.09% |
| MARSHALL WACE, LLP | 08/13/2025 | 40.18 K | $181.22 K | 100.00% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Y-mAbs Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 114 institutional investors and hedge funds held shares of Y-mAbs Therapeutics, Inc.. The most heavily invested institutionals were:
RHUMBLINE ADVISERS: 0
INTECH INVESTMENT MANAGEMENT LLC: 0
XTX Topco Ltd: 0
WELLS FARGO & COMPANY/MN: 0
Paradigm Biocapital Advisors LP: 0
UBS Group AG: 0
61.57% of Y-mAbs Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.97 M shares in the last 24 months. This purchase volume represents approximately $34.16 M in transactions.